Vaccine Allocation Decision on the allocation of COVAX Facility secured vaccines: 22 June 2022

Overview

COVAX Allocation Round 16 (R16) is the first allocation round of Phase 2 and allocates available vaccine supply to participants for a four month period, namely from July to October 2022 (inclusive).  As per COVAX Phase 2 principles and objectives, R16 focuses on meeting the demand expressed by AMC (Advance Market Commitment) participants in line with their national targets. Similarly to Rounds 14 and 15, and as per Phase 2 principles, APA (Advance Purchase Agreement) doses and donated doses are allocated together in R16.